360 related articles for article (PubMed ID: 25754088)
21. Detrended fluctuation analysis of genome-wide copy number profiles of glioblastomas using array-based comparative genomic hybridization.
Nakahara Y; Shiraishi T; Okamoto H; Mineta T; Oishi T; Sasaki K; Tabuchi K
Neuro Oncol; 2004 Oct; 6(4):281-9. PubMed ID: 15494095
[TBL] [Abstract][Full Text] [Related]
22. Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q.
Boström J; Cobbers JM; Wolter M; Tabatabai G; Weber RG; Lichter P; Collins VP; Reifenberger G
Cancer Res; 1998 Jan; 58(1):29-33. PubMed ID: 9426052
[TBL] [Abstract][Full Text] [Related]
23. PDGFRA amplification is common in pediatric and adult high-grade astrocytomas and identifies a poor prognostic group in IDH1 mutant glioblastoma.
Phillips JJ; Aranda D; Ellison DW; Judkins AR; Croul SE; Brat DJ; Ligon KL; Horbinski C; Venneti S; Zadeh G; Santi M; Zhou S; Appin CL; Sioletic S; Sullivan LM; Martinez-Lage M; Robinson AE; Yong WH; Cloughesy T; Lai A; Phillips HS; Marshall R; Mueller S; Haas-Kogan DA; Molinaro AM; Perry A
Brain Pathol; 2013 Sep; 23(5):565-73. PubMed ID: 23438035
[TBL] [Abstract][Full Text] [Related]
24. Correlation of EGFR, IDH1 and PTEN status with the outcome of patients with recurrent glioblastoma treated in a phase II clinical trial with the EGFR-blocking monoclonal antibody cetuximab.
Lv S; Teugels E; Sadones J; De Brakeleer S; Duerinck J; Du Four S; Michotte A; De Grève J; Neyns B
Int J Oncol; 2012 Sep; 41(3):1029-35. PubMed ID: 22752145
[TBL] [Abstract][Full Text] [Related]
25. Comprehensive portrait of recurrent glioblastoma multiforme in molecular and clinical characteristics.
Li R; Chen X; You Y; Wang X; Liu Y; Hu Q; Yan W
Oncotarget; 2015 Oct; 6(31):30968-74. PubMed ID: 26427041
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of MGMT promoter methylation and TP53 mutation in glioblastomas depends on IDH1 mutation.
Wang K; Wang YY; Ma J; Wang JF; Li SW; Jiang T; Dai JP
Asian Pac J Cancer Prev; 2014; 15(24):10893-8. PubMed ID: 25605197
[TBL] [Abstract][Full Text] [Related]
27. [A clinical and molecular study of long-term survival glioblastomas].
Wang X; Liu YH; Xie F; You C; Mao Q
Zhonghua Wai Ke Za Zhi; 2013 Feb; 51(2):166-70. PubMed ID: 23711013
[TBL] [Abstract][Full Text] [Related]
28. Mutational profiling of kinases in glioblastoma.
Bleeker FE; Lamba S; Zanon C; Molenaar RJ; Hulsebos TJ; Troost D; van Tilborg AA; Vandertop WP; Leenstra S; van Noorden CJ; Bardelli A
BMC Cancer; 2014 Sep; 14():718. PubMed ID: 25256166
[TBL] [Abstract][Full Text] [Related]
29. Whole-genome analysis of human astrocytic tumors by comparative genomic hybridization.
Maruno M; Ninomiya H; Ghulam Muhammad AK; Hirata M; Kato A; Yoshimine T
Brain Tumor Pathol; 2000; 17(1):21-7. PubMed ID: 10982006
[TBL] [Abstract][Full Text] [Related]
30. Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial.
Dubbink HJ; Atmodimedjo PN; Kros JM; French PJ; Sanson M; Idbaih A; Wesseling P; Enting R; Spliet W; Tijssen C; Dinjens WN; Gorlia T; van den Bent MJ
Neuro Oncol; 2016 Mar; 18(3):388-400. PubMed ID: 26354927
[TBL] [Abstract][Full Text] [Related]
31. Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network.
Weller M; Felsberg J; Hartmann C; Berger H; Steinbach JP; Schramm J; Westphal M; Schackert G; Simon M; Tonn JC; Heese O; Krex D; Nikkhah G; Pietsch T; Wiestler O; Reifenberger G; von Deimling A; Loeffler M
J Clin Oncol; 2009 Dec; 27(34):5743-50. PubMed ID: 19805672
[TBL] [Abstract][Full Text] [Related]
32. Epithelioid glioblastomas stratify into established diagnostic subsets upon integrated molecular analysis.
Korshunov A; Chavez L; Sharma T; Ryzhova M; Schrimpf D; Stichel D; Capper D; Sturm D; Kool M; Habel A; Kleinschmidt-DeMasters BK; Rosenblum M; Absalyamova O; Golanov A; Lichter P; Pfister SM; Jones DTW; Perry A; von Deimling A
Brain Pathol; 2018 Sep; 28(5):656-662. PubMed ID: 28990704
[TBL] [Abstract][Full Text] [Related]
33. Congenital glioblastoma: a clinicopathologic and genetic analysis.
Brat DJ; Shehata BM; Castellano-Sanchez AA; Hawkins C; Yost RB; Greco C; Mazewski C; Janss A; Ohgaki H; Perry A
Brain Pathol; 2007 Jul; 17(3):276-81. PubMed ID: 17465990
[TBL] [Abstract][Full Text] [Related]
34. Correlation among pathology, genotype, and patient outcomes in glioblastoma.
Homma T; Fukushima T; Vaccarella S; Yonekawa Y; Di Patre PL; Franceschi S; Ohgaki H
J Neuropathol Exp Neurol; 2006 Sep; 65(9):846-54. PubMed ID: 16957578
[TBL] [Abstract][Full Text] [Related]
35. Genomic landscape of gliosarcoma: distinguishing features and targetable alterations.
Zaki MM; Mashouf LA; Woodward E; Langat P; Gupta S; Dunn IF; Wen PY; Nahed BV; Bi WL
Sci Rep; 2021 Sep; 11(1):18009. PubMed ID: 34504233
[TBL] [Abstract][Full Text] [Related]
36. Genomic profiling reveals distinctive molecular relapse patterns in IDH1/2 wild-type glioblastoma.
Riehmer V; Gietzelt J; Beyer U; Hentschel B; Westphal M; Schackert G; Sabel MC; Radlwimmer B; Pietsch T; Reifenberger G; Weller M; Weber RG; Loeffler M;
Genes Chromosomes Cancer; 2014 Jul; 53(7):589-605. PubMed ID: 24706357
[TBL] [Abstract][Full Text] [Related]
37. Genetic profile of the giant cell glioblastoma.
Peraud A; Watanabe K; Schwechheimer K; Yonekawa Y; Kleihues P; Ohgaki H
Lab Invest; 1999 Feb; 79(2):123-9. PubMed ID: 10068201
[TBL] [Abstract][Full Text] [Related]
38. Sequencing the next generation of glioblastomas.
Jovčevska I
Crit Rev Clin Lab Sci; 2018 Jun; 55(4):264-282. PubMed ID: 29668342
[TBL] [Abstract][Full Text] [Related]
39. Differential diagnosis of small cell glioblastoma and anaplastic oligodendroglioma: a case report of an elderly man.
Takahashi K; Tsuda M; Kanno H; Murata J; Mahabir R; Ishida Y; Kimura T; Tanino M; Nishihara H; Nagashima K; Tanaka S
Brain Tumor Pathol; 2014 Apr; 31(2):118-23. PubMed ID: 23979650
[TBL] [Abstract][Full Text] [Related]
40. Genomic analysis reveals secondary glioblastoma after radiotherapy in a subset of recurrent medulloblastomas.
Phi JH; Park AK; Lee S; Choi SA; Baek IP; Kim P; Kim EH; Park HC; Kim BC; Bhak J; Park SH; Lee JY; Wang KC; Kim DS; Shim KW; Kim SH; Kim CY; Kim SK
Acta Neuropathol; 2018 Jun; 135(6):939-953. PubMed ID: 29644394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
